OssDsign Shares Update on PROPEL Spinal Fusion Study

Results show a fusion rate of 88.4% in a highly complex patient cohort, demonstrating that Catalyst nanosynthetic bone graft shows strong performance even in challenging patient populations.

Cerapedics Gains FDA Approval of PearlMatrix P-15 Bone Graft

PearlMatrix Bone Graft is the first and only bone growth accelerator proven to accelerate lumbar fusion.